INS and diabetes mellitus: The Diabetes Control and Complications Trial (DCCT) study established that in patients with insulin dependent diabetes mellitus, intensive insulin-therapy regimens with the aim of maintaining glycemic control as close to the normal HbA1c range as safely possible significantly decreases the risk of developing DR by 76%; this risk reduction also increased with time [26].